Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04789005
Status:
COMPLETED
Last Update Posted:
2021-03-09
First Post:
2021-02-10
Brief Title:
Comparison of Phenylephrine and Norepinephrine for Spinal-induced Hypotension
Sponsor:
Tribhuvan University Teaching Hospital Institute Of Medicine
Organization:
Tribhuvan University Teaching Hospital Institute Of Medicine
Study Overview
Official Title:
Comparison of Intravenous Phenylephrine and Norepinephrine for Treatment of Spinal-induced Hypotension in Caesarian Deliveries
Status:
COMPLETED
Status Verified Date:
2021-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hypotension after spinal anaesthesia for cesarean deliveries is frequently encountered Phenylephrine an α-agonist is commonly used for the prevention and treatment of spinal-induced hypotension Phenylephrine causes baroreceptor-mediated bradycardia leading to subsequent reduction in cardiac output Preservation of heart rate and cardiac output is important in high-risk conditions such as placental insufficiency fetal distress and maternal cardiac disease Recently norepinephrine has been found as effective as phenylephrine in treatment of spinal induced hypotension When norepinephrine is used as a bolus it is effective at maintaining blood pressure while also conferring a greater heart rate and cardiac output compared to phenylephrine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None